How Seqster CEO Ardy Arianpour is Solving Healthcare's Data Fragmentation

Ardy Arianpour, the CEO of health data platform Seqster, has transitioned from a high-stakes career in genetics to building a solution for one of the healthcare industry's most persistent problems: data fragmentation. After playing a pivotal role in the $1 billion acquisition of Ambry Genetics, Arianpour founded Seqster in 2016 to centralize disparate medical records. The platform now manages 150 million patient records and integrates with over 20 electronic health record systems, serving a client base that includes major Fortune 500 companies.

The platform’s value proposition was validated through personal necessity when Arianpour utilized his own technology to expedite life-saving care for his father and wife. By consolidating scattered medical histories, Seqster enabled rapid access to specialists and accelerated surgical timelines that would have otherwise taken months. This shift from mere data storage to actionable, life-saving intelligence defines the company's mission and distinguishes it in a crowded health-tech market.

Beyond its core record-aggregation capabilities, Seqster is aggressively expanding its technological footprint. The company recently launched an AI-powered clinical trial recruitment tool capable of screening 10,000 patients in under an hour, signaling a move toward high-speed, data-driven medical research. As healthcare systems continue to struggle with interoperability, Arianpour’s focus on turning fragmented information into immediate, clinical outcomes positions Seqster as a critical infrastructure player in the future of patient care.